Bioorganometallic compounds with antimalarial targets: Inhibiting hemozoin formation
Navarro, M., Castro, W. and Biot, C. (2012) Bioorganometallic compounds with antimalarial targets: Inhibiting hemozoin formation. Organometallics, 31 (16). pp. 5715-5727.
*Subscription may be required
About half of the world's population is at risk of malaria, and in tropical countries it remains a major cause of morbidity and death in children. Drug resistance to current established antimalarial drugs such as chloroquine is driving the rise in malaria-attributed deaths. In the mid-1990s, two groups-in France and in Venezuela-probed the potential contribution of organometallic analogues as a means of discovering new antimalarial drugs. In the present review, key topics of organometallic antimalarials are outlined using examples from the literature. The interdisciplinary research environment of bioorganometallics allows researchers to investigate the whole spectrum of the drugs' mechanisms of action. Targeting the digestive vacuole and inhibiting hemozoin formation is believed to be the main mechanism by which these drugs induce parasite death.
|Publication Type:||Journal Article|
|Murdoch Affiliation:||School of Chemical and Mathematical Science|
|Publisher:||American Chemical Society|
|Copyright:||© 2012 American Chemical Society|
|Item Control Page|